首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

北美臨床試驗影像市場預測至 2028 年 - 區域分析 - 按模式、產品（操作影像服務、影像軟體、讀取分析服務、試驗設計和諮詢服務等）和最終用戶

市場調查報告書

商品編碼

1360050

北美臨床試驗影像市場預測至 2028 年 - 區域分析 - 按模式、產品（操作影像服務、影像軟體、讀取分析服務、試驗設計和諮詢服務等）和最終用戶

North America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User

出版日期: 2023年07月27日 | 出版商:

The Insight Partners | 英文 124 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美臨床試驗影像市場預計將從2023年的7.0494億美元成長到2028年的10.2561億美元；預計2023年至2028年年複合成長率為7.8%。

提供醫學影像服務的 CRO 數量激增，推動北美臨床試驗影像市場

臨床研究組織 (CRO) 透過使用高品質設施和深厚的主題專業知識提供的服務，協助臨床試驗的成功實施。 CRO 已開始成為臨床試驗行業的支柱，其高效且具有成本效益的運作使試驗申辦者受益。例如，平均而言，CRO 進行和完成臨床試驗的時間比內部活動少 30%。隨著 CRO 數量的增加導致競爭加劇，其中一些企業提供專門的成像服務，從而成為成像 CRO (iCRO)。 iCRO 的一些例子包括 Keosys Medical Imaging 和 Medica Group PLC。 CRO 在成像現場鑑定、標準化影像擷取以及讀取設計和標準確定等領域提供關鍵知識見解，從而促進整個北美臨床試驗成像市場的成長。

北美臨床試驗影像市場概況

北美臨床試驗影像市場分為美國、加拿大和墨西哥。美國是臨床試驗成像最大且成長最快的市場。該地區的市場成長歸因於美國逐漸成為領先的臨床研究目的地，以及越來越多的公司推出用於臨床試驗的創新產品。美國已成為領先的臨床研究目的地。全球約一半的臨床試驗是在美國進行的。此外，由於成熟的醫療基礎設施、快速的核准時間表、有利的監管框架以及可接受的臨床試驗產生的資料，大多數製藥研究公司更願意在美國進行臨床試驗。

北美臨床試驗影像市場收入及 2028 年預測（百萬美元）

北美臨床試驗影像市場細分

北美臨床試驗成像市場根據模式、產品、最終用戶和國家進行細分。

根據模式，北美臨床試驗影像市場分為斷層掃描、磁振造影 (MRI)、超音波、正子斷層掃描 (PET)、X 光、超音波心動圖等。 2023 年，斷層掃描領域佔據了最大的市場。

根據產品類型，北美臨床試驗影像市場分為操作影像服務、影像軟體、讀取分析服務、試驗設計和諮詢服務等。 2023 年，營運影像服務領域佔據最大的市場佔有率。

根據最終用戶，北美臨床試驗影像市場分為合約研究組織（CRO）、製藥和生物技術公司、學術和研究機構等。合約研究組織 (CRO) 領域在 2023 年佔據最大的市場佔有率。

根據國家/地區，市場分為美國、加拿大和墨西哥。 2023 年，美國佔據市場佔有率主導地位。

BioTelemetry Inc、Calyx Inc、eResearch Technology Inc、ICON PLC、IXICO plc、Medical Metrics Inc、Medpace Holdings Inc、VIDA Diagnostics Inc 和 WCG Clinical Inc 是北美臨床試驗成像市場的領先公司。

Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, a few of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). A few examples of iCROs include Keosys Medical Imaging and Medica Group PLC. CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall North America clinical trial imaging market.

North America Clinical Trial Imaging Market Overview

The North America clinical trial imaging market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trial imaging. The market growth in the region is attributed to the US emerging as a leading clinical research destination and a growing number of innovative product launches by companies for applications in clinical trials. The US has emerged as a leading clinical research destination. Approximately half of the total clinical trials conducted globally are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial-generated data.

North America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)

North America Clinical Trial Imaging Market Segmentation

The North America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.

Based on modality, the North America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.

Based on offering, the North America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.

Based on end user, the North America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.

Based on country, the market is segmented into US, Canada, and Mexico. The US dominated the market share in 2023.

BioTelemetry Inc, Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Medpace Holdings Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the North America clinical trial imaging market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America clinical trial imaging market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies
develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the clinical trial imaging market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 North America Market Segmentation
- 1.3.1 North America Clinical Trial Imaging Market - by Modality
- 1.3.2 North America Clinical Trial Imaging Market - by Offering
- 1.3.3 North America Clinical Trial Imaging Market - by End User
- 1.3.4 North America Clinical Trial Imaging Market - by Country

2. North America Clinical Trial Imaging Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Clinical Trial Imaging Market - Market Landscape

4.1 Overview
- 4.1.1 North America PEST Analysis
4.2 Expert Opinion

5. North America Clinical Trial Imaging Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
- 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
5.2 Market Restraints
- 5.2.1 High Investment and Standardized Infrastructure Requirements
5.3 Market Opportunities
- 5.3.1 In-Silico Imaging Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. North America Clinical Trial Imaging Market

6.1 North America Clinical Trial Imaging Market Revenue Forecast and Analysis

7. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality

7.1 Overview
7.2 North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
7.3 Tomography
- 7.3.1 Overview
- 7.3.2 Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Ultrasound
- 7.4.1 Overview
- 7.4.2 Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Positron Emission Tomography
- 7.5.1 Overview
- 7.5.2 PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.6 X-Ray
- 7.6.1 Overview
- 7.6.2 X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Echocardiography
- 7.7.1 Overview
- 7.7.2 Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Magnetic Resonance Imaging
- 7.8.1 Overview
- 7.8.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering

8.1 Overview
8.2 North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
8.3 Trial Design Consulting Services
- 8.3.1 Overview
- 8.3.2 Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Read Analysis Services
- 8.4.1 Overview
- 8.4.2 Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Operational Imaging Services
- 8.5.1 Overview
- 8.5.2 Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Imaging Software
- 8.6.1 Overview
- 8.6.2 Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User

9.1 Overview
9.2 Pharmaceutical and Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.3 Contract Research Organizations
- 9.3.1 Overview
- 9.3.2 Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
  - 10.1.1.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)

11. Clinical Trial Imaging Market - Industry Landscape

11.1 Overview
11.2 Inorganic Growth Strategies
- 11.2.1 Overview
11.3 Organic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 eResearch Technology Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Calyx Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 ICON PLC
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 VIDA Diagnostics Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 WCG Clinical Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BioTelemetry Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medical Metrics Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medpace Holdings Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 IXICO plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Clinical Trial Imaging Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Clinical Trial Imaging Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Clinical Trial Imaging Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
Table 12. Recent Organic Growth Strategies in Clinical Trial Imaging Market
Table 13. Glossary of Terms

List Of Figures

Figure 1. North America Clinical Trial Imaging Market Segmentation
Figure 2. North America Clinical Trial Imaging Market, by Country
Figure 3. North America Clinical Trial Imaging Market Overview
Figure 4. North America Clinical Trial Imaging Market, By Modality
Figure 5. North America Clinical Trial Imaging Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. North America Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
Figure 8. North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
Figure 9. Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
Figure 17. Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
Figure 23. Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. North America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
Figure 29. US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)